CN100337651C - Chinese medicine composition for preventing bird flu - Google Patents
Chinese medicine composition for preventing bird flu Download PDFInfo
- Publication number
- CN100337651C CN100337651C CNB2005100114323A CN200510011432A CN100337651C CN 100337651 C CN100337651 C CN 100337651C CN B2005100114323 A CNB2005100114323 A CN B2005100114323A CN 200510011432 A CN200510011432 A CN 200510011432A CN 100337651 C CN100337651 C CN 100337651C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- weight
- medicine composition
- coarse powder
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种用于预防鸡、鸭等家禽禽流感的内服中药组合物及其制备方法和应用。The invention relates to an oral Chinese medicinal composition for preventing poultry such as chickens and ducks from avian influenza, a preparation method and application thereof.
背景技术Background technique
禽流感是A型禽流感病毒所引起的禽类的一种急性高度致死性传染病。鸡、火鸡、鸭和鹌鹑等家禽及野鸟、水禽、海鸟等均可感染,但以鸡和火鸡为主。猪、猫、猴等多种动物和人类也可感染。Avian influenza is an acute and highly fatal infectious disease of poultry caused by type A avian influenza virus. Poultry such as chickens, turkeys, ducks, and quails, as well as wild birds, waterfowl, and seabirds can be infected, but chickens and turkeys are the main ones. Pigs, cats, monkeys and other animals and humans can also be infected.
禽流感最早于1878年发生在意大利,历史上曾被称为鸡瘟或真性鸡瘟。一百多年来,禽流感不断地侵袭着整个世界的养禽业,并直接威胁人类的健康和生命。1997年,香港爆发的禽流感导致家禽大规模死亡,并先后有18人感染禽流感病毒,其中6人死亡;2003年12月至2004年3月在东南亚爆发的H5N1型禽流感波及几乎所有的东南亚国家和地区,造成数千万只家禽染病死亡,及20余人感染禽流感病毒而死亡。Avian influenza first occurred in Italy in 1878, and was historically known as fowl plague or true fowl plague. For more than 100 years, bird flu has continuously attacked the poultry industry in the whole world and directly threatened human health and life. In 1997, the outbreak of bird flu in Hong Kong led to large-scale deaths of poultry, and 18 people were infected with bird flu virus, of which 6 died; from December 2003 to March 2004, the outbreak of H5N1 bird flu in Southeast Asia affected almost all In Southeast Asian countries and regions, tens of millions of poultry were infected and died, and more than 20 people were infected with bird flu virus and died.
虽然禽流感被发现已有100多年的历史,但至今人类尚未掌握完全有效的预防、治疗和控制技术。禽流感疫苗是预防禽流感爆发的主要手段。如果使用的疫苗与侵袭的病毒的亚型一致,则疫苗对家禽的保护率可达到90%以上。但目前已分离出的禽流感具有15种H抗原和9种N抗原,两种抗原的不同组合可以形成上百个血清亚型,而且流行的病毒亚型不稳定,产生“漂移”,这给疫苗的研制及禽流感的诊断和防治带来很大困难。Although avian influenza has been discovered for more than 100 years, humans have not yet mastered fully effective prevention, treatment and control technologies. Avian influenza vaccine is the main means of preventing outbreaks of avian influenza. If the vaccine used is consistent with the subtype of the invading virus, the protection rate of the vaccine to poultry can reach more than 90%. However, the isolated avian influenza has 15 kinds of H antigens and 9 kinds of N antigens. Different combinations of the two antigens can form hundreds of serotypes, and the popular virus subtypes are unstable, resulting in "drift". The development of vaccines and the diagnosis and control of bird flu have brought great difficulties.
病毒是寄生于宿主活细胞内的微生物,凡对病毒有抑制或杀灭作用的药物,对宿主细胞也有一定毒性,这给抗病毒药物的研制带来很大困难。目前针对流感和禽流感病毒的化疗药物主要是金刚烷胺和金刚乙胺。利巴韦林是一种广谱抗病毒药物,临床上也常用于治疗流感,但病毒抑制试验表明,利巴韦林在体外对流感病毒并无抑制作用。金刚烷胺和金刚乙胺在应用初期对预防鸡、鸭禽流感具有较好效果,但随着这类药物的普遍、长期应用,禽流感病毒已对这类药物产生严重抗药性,致使这类药物在临床上应用无明显效果。1999年上市的抗流感新药扎那米韦(Zaramivir)和奥司米韦(Oseltamivir)对人流感有确切的防治效果,对家禽禽流感的预防未见报道。但这两种药价格昂贵,即使对禽流感有效也难以用于养禽业。因此在禽流感的防治中,至今还没有理想的化疗药物。Viruses are microorganisms that parasitize in the living cells of the host. Any drug that can inhibit or kill the virus is also toxic to the host cell, which brings great difficulties to the development of antiviral drugs. Currently, amantadine and rimantadine are the main chemotherapeutic drugs for influenza and avian influenza viruses. Ribavirin is a broad-spectrum antiviral drug, which is also commonly used clinically to treat influenza, but the virus inhibition test shows that ribavirin has no inhibitory effect on influenza virus in vitro. Amantadine and rimantadine have a good effect on preventing avian influenza in chickens and ducks in the early stage of application, but with the widespread and long-term application of this type of drug, the avian influenza virus has developed serious drug resistance to this type of drug, resulting in this type of drug. The drug has no obvious effect in clinical application. The new anti-influenza drugs Zaramivir and Oseltamivir launched in 1999 have definite control effects on human influenza, but there is no report on the prevention of poultry avian influenza. However, these two drugs are expensive, and even if they are effective against bird flu, they are difficult to use in the poultry industry. Therefore, in the prevention and treatment of bird flu, there is no ideal chemotherapeutic drug so far.
在我国,中医中药用于防治人的感冒和流感已有逾千年的历史,积累了丰富的经验。人医用于治疗感冒和流感的中药主要是清热解毒类中药和解表类中药,前者有连翘、金银花、黄芩、鱼腥草、板蓝根、大青叶、野菊花、桑叶、牛蒡子、蒲公英、牛黄等,后者有生姜、桂枝、麻黄、柴胡、荆芥、紫苏、辛夷、薄荷等。此外,黄芪、防风等中药对人体免疫有显著促进调节作用,也是常用的防治感冒药物。用于防治人感冒的中成药也品种繁多,较著名的有“银翘片”、“双黄连”、“清开灵”、“桂枝麻黄汤”等。In my country, traditional Chinese medicine has been used for the prevention and treatment of human colds and flu for more than a thousand years, and has accumulated rich experience. The traditional Chinese medicines used by human medicine to treat colds and flu are mainly heat-clearing and detoxifying traditional Chinese medicines and exterior traditional Chinese medicines. The former includes forsythia, honeysuckle, scutellaria baicalensis, Houttuynia cordata, Radix Isatidis, Daqingye, wild chrysanthemum, mulberry leaves, burdock, dandelion, Bezoar, etc. The latter includes ginger, cinnamon sticks, ephedra, Bupleurum, nepeta, perilla, magnolia, mint, etc. In addition, traditional Chinese medicines such as Astragalus and Fangfeng can significantly promote and regulate human immunity, and are also commonly used medicines for preventing and treating colds. There are also many kinds of Chinese patent medicines used to prevent and treat colds. The more famous ones include "Yinqiao Tablet", "Shuanghuanglian", "Qingkailing", "Guizhi Mahuang Decoction" and so on.
随着我国畜禽养殖业的迅速发展和兽医药研究的不断深入,中药在畜禽疾病防治上的应用也越来越普遍,对提高畜禽的成活率和健康水平起到了积极作用。但总的来看,目前我国的中兽药还处于药物配伍缺少系统研究、产品剂型粗糙、有效成分不明确、产品质量不稳定的低技术水平。应用中药防治家禽禽流感的研究报道很少,未见有系统深入的研究报道,兽药市场也未见对禽流感有很好防治效果的中兽药产品。With the rapid development of my country's livestock and poultry breeding industry and the continuous deepening of veterinary medicine research, the application of traditional Chinese medicine in the prevention and treatment of livestock and poultry diseases has become more and more common, which has played a positive role in improving the survival rate and health level of livestock and poultry. But in general, at present, my country's traditional Chinese veterinary medicine is still at a low technical level with lack of systematic research on drug compatibility, rough product dosage forms, unclear active ingredients, and unstable product quality. There are very few research reports on the application of traditional Chinese medicine to prevent and treat poultry avian influenza, and there are no systematic and in-depth research reports, and there is no Chinese veterinary drug product that has a good control effect on avian influenza in the veterinary drug market.
发明内容Contents of the invention
本发明的目的在于提供一种对鸡、鸭等家禽禽流感有显著预防效果的中药组合物及其制备方法和应用。The object of the present invention is to provide a traditional Chinese medicine composition which has a significant preventive effect on chickens, ducks and other poultry avian influenza, as well as its preparation method and application.
为了实现上述目的,本发明采取如下的技术方案:In order to achieve the above object, the present invention takes the following technical solutions:
本发明预防禽流感的中药组合物,它由按重量份计的下列有效成分制成:连翘90-110重量份、金银花40-60重量份、北板兰根25-45重量份、黄芩40-60重量份、绵马贯众40-60重量份、黄芪70-90重量份。The traditional Chinese medicine composition for preventing bird flu of the present invention is made of the following active ingredients in parts by weight: 90-110 parts by weight of Forsythia, 40-60 parts by weight of Flos Lonicerae, 25-45 parts by weight of Radix Isatidis, and 40-60 parts by weight of Scutellaria baicalensis parts by weight, Mianma Guanzhong 40-60 parts by weight, and Radix Astragali 70-90 parts by weight.
优选地,连翘100重量份、金银花50重量份、北板兰根35重量份、黄芩50重量份、绵马贯众50重量份、黄芪80重量份。更优选为连翘1000g、金银花500g、北板兰根350g、黄芩500g、绵马贯众500g、黄芪800g。Preferably, 100 parts by weight of forsythia, 50 parts by weight of honeysuckle, 35 parts by weight of banlangen, 50 parts by weight of scutellaria baicalensis, 50 parts by weight of Mianma Guanzhong, and 80 parts by weight of astragalus. More preferably, it is 1000g of forsythia, 500g of honeysuckle, 350g of banlangen, 500g of scutellaria baicalensis, 500g of Mianmaguanzhong, and 800g of astragalus.
本发明的中药组合物剂型是散剂、饮水剂或颗粒冲剂。The dosage form of the traditional Chinese medicine composition of the present invention is a powder, a drinking water preparation or a granule electuary.
本发明中药组合物的制备方法,包括如下步骤:The preparation method of Chinese medicine composition of the present invention, comprises the steps:
(1)将连翘、金银花、北板兰根、黄芩、绵马贯众、黄芪分别粉碎成粗粉;(1) Pulverize forsythia, honeysuckle, banlangen, scutellaria baicalensis, Mianma Guanzhong and astragalus into coarse powder respectively;
(2)取步骤(1)连翘粗粉用乙醇水溶液作溶剂进行渗漉提取,收集渗漉液;(2) take step (1) forsythia coarse powder and use ethanol aqueous solution as solvent to carry out percolation extraction, collect percolation liquid;
(3)取步骤(1)制得的金银花粗粉、北板兰根粗粉、黄芩粗粉、绵马贯众粗粉,用乙醇水溶液作溶剂,进行渗漉提取,收集渗漉液;(3) Take the honeysuckle coarse powder, northern root powder, Scutellaria baicalensis coarse powder, Mianmaguanzhong coarse powder obtained in step (1), use ethanol aqueous solution as solvent, carry out percolation extraction, and collect percolation liquid;
(4)取经步骤(1)制得的黄芪粗粉用蒸馏水作溶剂,进行渗漉提取,收集渗漉液;(4) take the astragalus powder obtained through step (1) and use distilled water as a solvent, carry out percolation extraction, and collect percolation liquid;
(5)合并(2)、(3)、(4)步骤的渗漉液,静置,过滤,减压蒸馏回收乙醇,剩余药液在温度65-75℃、真空度0.02-0.04Mpa下减压浓缩成稠膏,加入辅料制成所需剂型。(5) Merge (2), (3), (4) percolation liquid of step, leave standstill, filter, decompression distillation reclaims ethanol, and remaining liquid medicine is reduced under temperature 65-75 ℃, vacuum tightness 0.02-0.04Mpa Compress and condense into a thick paste, and add auxiliary materials to make the required dosage form.
本发明的中药组合物的又一种制备方法,包括如下步骤:按权利要求1所述重量份称取连翘、金银花、北板兰根、黄芩、绵马贯众、黄芪,并分别粉碎成粗粉,按水煎煮法煎煮,收集各次煎出液,沉降过滤后,在温度65-75℃、真空度0.02-0.04Mpa下减压浓缩至药液的重量为中药原材料总重量的1.0±0.1倍,往浓缩药液中加入0.1%的苯甲酸钠和0.05%的尼泊金作防腐剂,即得饮水剂。Yet another preparation method of the traditional Chinese medicine composition of the present invention comprises the steps of: weighing forsythia, honeysuckle, banlangen, scutellaria baicalensis, Mianmaguanzhong, and astragalus in parts by weight according to claim 1, and pulverizing them into coarse powder respectively , decoct according to the water decoction method, collect each decoction liquid, settle and filter, then concentrate under reduced pressure at a temperature of 65-75°C and a vacuum of 0.02-0.04Mpa until the weight of the liquid medicine is 1.0±1.0% of the total weight of the raw materials of traditional Chinese medicine. 0.1 times, add 0.1% sodium benzoate and 0.05% paraben as preservatives to the concentrated medicinal solution to obtain drinking water.
本发明的中药组合物在制备用于预防禽流感的药物中的应用。The application of the traditional Chinese medicine composition of the invention in the preparation of medicines for preventing bird flu.
本发明首先利用“禽流感病毒鸡胚攻毒试验”(以下简称“鸡胚试验”)对40余种清热解毒和解表类中药进行筛选,发现绵马贯众、连翘、金银花、黄芩、鱼腥草、板蓝根、大青叶、甘草、贯叶连翘、柴胡等十余种中药对鸡胚内禽流感病毒有显著抑制作用。然后利用筛选出的上述药物进行不同的组方,分别用水煮和醇提两种方法提取药效成分。最后对复方进行鸡胚试验和人工发病禽流感鸡治疗试验,筛选出效果较好的复方。根据试验结果,最终确定以连翘、金银花、北板兰根、黄芩、绵马贯众、黄芪等6味中药为原料进行组方,该方对鸡、鸭禽流感有显著防治效果。方中前5味药均为清热解毒之要药,对禽流感病毒都有较强抑制作用;各味药协同作用,不仅加强了对病毒、细菌的抑制作用,而且减少了单味药的毒性及病毒耐药性的产生。其中,连翘主含苯乙醇咖啡酸甙类化合物,绵马贯众主含绵马素、三叉厥酚,金银花主含绿原酸,板蓝根主含靛蓝、靛玉红,黄芩主含黄芩甙、汉黄芩素,这些成分对细菌及病毒均有不同程度的抑制活性。黄芪含黄芪多糖,黄芪多糖对人和动物的免疫活性有显著的促进作用,能明显增强巨噬细胞的吞噬功能,增加TNF分泌,促进病毒抗体的生成。Firstly, the present invention screens more than 40 kinds of traditional Chinese medicines for clearing away heat, detoxifying and expelling symptoms by using the "Chicken Embryo Challenge Test of Avian Influenza Virus" (hereinafter referred to as "Chicken Embryo Test"), and finds Mianmaguanzhong, Forsythia, Honeysuckle, Scutellaria baicalensis, fish More than ten kinds of traditional Chinese medicines such as Xingcao, Radix Isatidis, Folium Isatidis, Licorice, Hypericum perforatum, and Bupleurum have significant inhibitory effects on avian influenza virus in chicken embryos. Then, different formulations are carried out by using the above-mentioned drugs screened out, and the effective components are extracted by two methods of water boiling and alcohol extraction respectively. Finally, the chicken embryo test and artificially infected bird flu chicken treatment test were carried out on the compound formula, and the compound formula with better effect was screened out. According to the test results, it was finally determined that six traditional Chinese medicines such as forsythia, honeysuckle, banlangen, scutellaria baicalensis, Mianmaguanzhong, and astragalus were used as raw materials to make a prescription, which has a significant effect on preventing and controlling avian influenza in chickens and ducks. The first five herbs in the prescription are all essential medicines for clearing away heat and detoxifying, and they all have a strong inhibitory effect on avian influenza virus; the synergistic effect of each herb not only strengthens the inhibitory effect on viruses and bacteria, but also reduces the toxicity of a single herb and the development of viral resistance. Among them, forsythia mainly contains phenylethanol caffeic acid glycosides, Mianma Guanzhong mainly contains mianmasu and trigeminol, honeysuckle mainly contains chlorogenic acid, Radix isatidis mainly contains indigo and indirubin, and Scutellaria baicalensis mainly contains baicalin, Wogonin, these components have different degrees of inhibitory activity on bacteria and viruses. Astragalus contains astragalus polysaccharides, which can significantly promote the immune activity of humans and animals, significantly enhance the phagocytosis of macrophages, increase TNF secretion, and promote the production of virus antibodies.
具体实施方式Detailed ways
实施例1Example 1
本发明散剂的制备方法,包括如下步骤:The preparation method of powder of the present invention, comprises the steps:
(1)称取连翘10000g、金银花5000g、北板兰根3500g、黄芩5000g、绵马贯众5000g、黄芪8000g,并分别粉碎成粗粉;(1) Weigh 10000g of forsythia, 5000g of honeysuckle, 3500g of orchid root, 5000g of scutellaria baicalensis, 5000g of Mianmaguanzhong, and 8000g of astragalus, and grind them into coarse powder respectively;
(2)取连翘粗粉用80%乙醇作溶剂,照流浸膏剂渗漉法进行渗漉,2.5ml/kg.min,收集渗漉液;(2) Take the forsythia coarse powder and use 80% ethanol as solvent, carry out percolation according to the liquid extract percolation method, 2.5ml/kg.min, collect percolation liquid;
(3)取经步骤(1)制得的金银花粗粉、北板兰根粗粉、黄芩粗粉、绵马贯众粗粉,用60%乙醇作溶剂,照流浸膏剂渗漉法进行渗漉,3ml/kg.min,收集渗漉液;(3) Get honeysuckle coarse powder, northern banlangen coarse powder, Scutellaria baicalensis coarse powder, Mianmaguanzhong coarse powder through step (1), make solvent with 60% ethanol, carry out percolation according to the liquid extract percolation method, 3ml /kg.min, collect percolate;
(4)取经步骤(1)制得的黄芪粗粉用蒸馏水作溶剂,照流浸膏剂渗漉法进行渗漉,3ml/kg.min,收集渗漉液;(4) Get the astragalus powder obtained through step (1) and use distilled water as a solvent, carry out percolation according to the liquid extract percolation method, 3ml/kg.min, collect percolation liquid;
(5)合并(2)、(3)、(4)步骤中的渗漉液,静置,过滤,减压蒸馏(5) Combine the percolation liquid in (2), (3), and (4) steps, leave standstill, filter, and distill under reduced pressure
回收乙醇,剩余药液在温度65℃、真空度0.02Mpa下减压浓缩成稠膏,喷雾干燥或减压干燥,粉碎过60目筛,得干燥细粉;Recover ethanol, concentrate the remaining medicinal solution under reduced pressure at a temperature of 65°C and a vacuum of 0.02Mpa to form a thick paste, spray dry or dry under reduced pressure, and pulverize through a 60-mesh sieve to obtain a dry fine powder;
(6)往步骤(5)干燥细粉中加入1.5%的白炭黑,即得散剂。其中白炭黑的作用在于改善流散性,减少吸潮性。本发明的散剂为流散性良好的粉末或粉末状颗粒,呈棕色或棕褐色,味苦。(6) Add 1.5% white carbon black to the dried fine powder in step (5) to obtain a powder. Among them, the role of silica is to improve fluidity and reduce moisture absorption. The powder of the present invention is powder or powdery granules with good fluidity, brown or tan color, and bitter taste.
实施例2Example 2
本发明颗粒冲剂的制备方法,包括如下步骤:The preparation method of granule electuary of the present invention, comprises the steps:
(1)称取连翘9000g、金银花5000g、北板兰根3500g、黄芩5000g、绵马贯众5000g、黄芪7000g,并分别粉碎成粗粉;(1) Weigh 9000g of forsythia, 5000g of honeysuckle, 3500g of orchid root, 5000g of scutellaria baicalensis, 5000g of Mianma Guanzhong, and 7000g of astragalus, and grind them into coarse powder respectively;
(2)取连翘粗粉用70%乙醇作溶剂,照流浸膏剂渗漉法进行渗漉,2.5ml/kg.min,收集渗漉液;(2) Take the forsythia coarse powder and use 70% ethanol as solvent, carry out percolation according to the liquid extract percolation method, 2.5ml/kg.min, collect percolation liquid;
(3)取经步骤(1)制得的金银花粗粉、北板兰根粗粉、黄芩粗粉、绵马贯众粗粉,用50%乙醇作溶剂,照流浸膏剂渗漉法进行渗漉,2.5ml/kg.min,收集渗漉液;(3) get through the honeysuckle coarse powder that step (1) makes, northern banlangen coarse powder, Scutellaria baicalensis coarse powder, Mianma Guanzhong coarse powder, make solvent with 50% ethanol, carry out percolation according to the liquid extract percolation method, 2.5 ml/kg.min, collect percolate;
(4)取经步骤(1)制得的黄芪粗粉用蒸馏水作溶剂,照流浸膏剂渗漉法进行渗漉,3ml/kg.min,收集渗漉液;(4) Get the astragalus powder obtained through step (1) and use distilled water as a solvent, carry out percolation according to the liquid extract percolation method, 3ml/kg.min, collect percolation liquid;
(5)合并(2)、(3)、(4)步骤的渗漉液,静置,过滤,减压蒸馏回收乙醇,剩余药液在温度75℃、真空度0.03Mpa下减压浓缩成相对密度为1.37的稠膏;(5) Combine (2), (3), (4) percolation liquid of step, leave standstill, filter, underpressure distillation reclaims ethanol, remaining medicinal liquid is concentrated under reduced pressure at temperature 75 ℃, vacuum degree 0.03Mpa to relative thick paste with a density of 1.37;
(6)向步骤(5)的稠膏加入蔗糖粉适量,蔗糖占颗粒剂成品重量的28%,混匀,制成颗粒,烘箱干燥即得颗粒冲剂。(6) Add an appropriate amount of sucrose powder to the thick paste in step (5), the sucrose accounts for 28% of the weight of the finished granules, mix well, make granules, and dry in an oven to obtain granules.
实施例3Example 3
本发明饮水剂的制备方法,包括如下步骤:The preparation method of water-drinking agent of the present invention, comprises the steps:
(1)称取连翘1100g、金银花500g、北板兰根300g、黄芩600g、绵马贯众400g、黄芪800g,并分别粉碎成粗粉;(1) Weigh 1100g of Forsythia, 500g of Flos Lonicerae, 300g of Banlangen, 600g of Radix Scutellariae, 400g of Mianma Guanzhong, and 800g of Radix Astragali, and grind them into coarse powder respectively;
(2)取连翘粗粉用70%乙醇作溶剂,照流浸膏剂渗漉法进行渗漉,2.5ml/kg.min,收集渗漉液;(2) Take the forsythia coarse powder and use 70% ethanol as solvent, carry out percolation according to the liquid extract percolation method, 2.5ml/kg.min, collect percolation liquid;
(3)取经步骤(1)制得的金银花粗粉、北板兰根粗粉、黄芩粗粉、绵马贯众粗粉,用50%乙醇作溶剂,照流浸膏剂渗漉法进行渗漉,2.5ml/kg.min,收集渗漉液;(3) get through the honeysuckle coarse powder that step (1) makes, northern banlangen coarse powder, Scutellaria baicalensis coarse powder, Mianma Guanzhong coarse powder, make solvent with 50% ethanol, carry out percolation according to the liquid extract percolation method, 2.5 ml/kg.min, collect percolate;
(4)取经步骤(1)制得的黄芪粗粉用蒸馏水作溶剂,照流浸膏剂渗漉法进行渗漉,3.0ml/kg.min,收集渗漉液;(4) Get the astragalus powder obtained through step (1) and use distilled water as a solvent, carry out percolation according to the liquid extract percolation method, 3.0ml/kg.min, collect percolation liquid;
(5)合并渗漉液,静置,过滤,减压蒸馏回收乙醇,剩余药液在温度65℃、真空度0.02Mpa下减压浓缩得重量为3700g的浓缩药液;(5) Combine the percolation liquid, let it stand, filter, and recover ethanol by distillation under reduced pressure, and the remaining medicinal liquid is concentrated under reduced pressure at a temperature of 65°C and a vacuum of 0.02Mpa to obtain a concentrated medicinal liquid with a weight of 3700g;
(6)往步骤(5)的浓缩药液中加入0.1%的苯甲酸钠和0.05%的尼泊金作防腐剂,即得饮水剂。(6) Add 0.1% sodium benzoate and 0.05% paraben to the concentrated medicinal solution in step (5) as preservatives to obtain drinking water.
实施例4Example 4
本发明饮水剂的又一种制备方法,包括如下步骤:Yet another preparation method of the drinking water formulation of the present invention comprises the following steps:
称取连翘1050g、金银花400g、北板兰根450g、黄芩400g、绵马贯众600g、黄芪700g,并分别粉碎成粗粉;按水煎煮法煎煮,收集各次煎出液,沉降过滤后,在温度72℃、真空度0.04Mpa下减压浓缩至药液的重量为3600g,该浓缩药液的重量在3240g-3960g范围内都是可行的。往浓缩药液中加入0.1%的苯甲酸钠和0.05%的尼泊金作防腐剂,即得饮水剂。Weigh 1050g forsythia, 400g honeysuckle, 450g beibanlangen, 400g scutellaria baicalensis, 600g mianmaguanzhong, and 700g astragalus membranaceus, and grind them into coarse powder respectively; decoct according to the water decoction method, collect each decoction liquid, settle and filter , concentrated under reduced pressure at a temperature of 72°C and a vacuum of 0.04Mpa until the weight of the medicinal solution is 3600g, and the weight of the concentrated medicinal solution is feasible within the range of 3240g-3960g. Add 0.1% sodium benzoate and 0.05% paraben as preservatives to the concentrated medicinal liquid to obtain drinking water.
实施例5:本发明的散剂Embodiment 5: powder of the present invention
按照实施例1所述的方法,不同之处是选用下列重量的原料:连翘9500g、金银花4500g、北板兰根3000g、黄芩5500g、绵马贯众6000g、黄芪8500g。According to the method described in Example 1, the difference is that the raw materials of the following weights are selected: 9500g forsythia, 4500g honeysuckle, 3000g Beibanlangen, 5500g Scutellaria baicalensis, 6000g Mianmaguanzhong, and 8500g Radix Astragali.
实施例6:本发明的颗粒冲剂Embodiment 6: Granule electuary of the present invention
按照实施例2所述的方法,不同之处是选用下列重量的原料:连翘10500g、金银花5500g、北板兰根4000g、黄芩4500g、绵马贯众5000g、黄芪7500g。According to the method described in Example 2, the difference is that the raw materials of the following weights are selected: 10500g forsythia, 5500g honeysuckle, 4000g Beibanlangen, 4500g Scutellaria baicalensis, 5000g Mianmaguanzhong, and 7500g Radix Astragali.
实施例7:本发明的饮水剂Embodiment 7: drinking water preparation of the present invention
按照实施例3所述的方法,不同之处是选用下列重量的原料:连翘920g、金银花420g、北板兰根260g、黄芩580g、绵马贯众520g、黄芪710g。According to the method described in Example 3, the difference is that the following raw materials are selected by weight: 920g forsythia, 420g honeysuckle, 260g northern banlangen, 580g scutellaria baicalensis, 520g Mianmaguanzhong, and 710g astragalus.
实施例8:本发明的饮水剂Embodiment 8: drinking water preparation of the present invention
按照实施例4所述的方法,不同之处是选用下列重量的原料:连翘1080g、金银花580g、北板兰根430g、黄芩430g、绵马贯众590g、黄芪870g。According to the method described in Example 4, the difference is that the following raw materials are selected by weight: 1080g forsythia, 580g honeysuckle, 430g Beibanlangen, 430g Scutellaria baicalensis, 590g Mianmaguanzhong, and 870g Radix Astragali.
本发明的药物可以采用中药制剂的常规方法制备成任何常规内服中药制剂。例如,超微粉剂、片剂等。但是为了便于给鸡、鸭群体用药,本发明优选饮水剂、颗粒冲剂、散剂等。散剂作饲料添加用药,饮水剂和颗粒冲剂作饮水添加用药。但是这些不能用于限制本发明的保护范围。The medicine of the present invention can be prepared into any conventional oral Chinese medicine preparation by adopting the conventional method of Chinese medicine preparation. For example, ultrafine powder, tablet, etc. But for the convenience of giving chickens and ducks groups medication, the present invention preferably drink water preparations, granule granules, powders and the like. Powders are used as feed additives, and drinking water and granules are used as drinking water additives. But these should not be used to limit the protection scope of the present invention.
本发明的中药组合物预防禽流感的用量分别是:The consumption of Chinese medicine composition prevention bird flu of the present invention is respectively:
(1)散剂用于预防鸡、鸭禽流感,在饲料中的添加量为每吨饲料1500克至2000克;用于治疗鸡、鸭禽流感,在饲料中的添加量为每吨饲料2500克至3000克;(1) The powder is used to prevent chicken and duck avian influenza, the amount added to the feed is 1500 grams to 2000 grams per ton of feed; for the treatment of chicken and duck avian influenza, the amount added to the feed is 2500 grams per ton of feed up to 3000 grams;
(2)饮水剂用于预防鸡、鸭禽流感,在适量的饮水中添加量为鸡、鸭每1000克体重每天用饮水剂3-5ml;用于治疗鸡、鸭禽流感,在适量的饮水中添加量为鸡、鸭每1000克体重每天用饮水剂6-8ml;(2) Drinking water agent is used to prevent chickens and ducks from bird flu, and the amount added in appropriate drinking water is 3-5ml of drinking water agent per 1000 grams of body weight of chickens and ducks per day; The amount added is 6-8ml of drinking water per 1000 grams of body weight for chickens and ducks per day;
(3)颗粒冲剂用于预防鸡、鸭禽流感,在适量的饮水中添加量为鸡、鸭每1000克体重每天用冲剂0.4-0.6克;用于治疗鸡、鸭禽流感,在适量的饮水中添加量为鸡、鸭每1000克体重每天用冲剂0.7-0.9克。(3) Granular granules are used to prevent bird flu in chickens and ducks. Add 0.4-0.6 grams of granules per 1000 grams of body weight of chickens and ducks in an appropriate amount of drinking water; The amount added is 0.7-0.9 grams of granules per 1000 grams of body weight per day for chickens and ducks.
以下通过试验例进一步说明本发明所述预防禽流感的中药复议制剂的动物急性毒性、药效以及临床前对禽流感鸡的防治效果。The animal acute toxicity, drug efficacy and pre-clinical control effect on bird flu chickens of the traditional Chinese medicine reconsideration preparation for preventing bird flu described in the present invention are further illustrated below through test examples.
试验一:中药组合物的动物急性毒性试验Test 1: Animal acute toxicity test of traditional Chinese medicine composition
材料与方法Materials and Methods
动物:昆明种小鼠,体重为20.3±1.2g,雌雄各半。从广州军区后勤部军事医学研究所购进。Animals: Kunming mice, weighing 20.3±1.2g, half male and half male. Purchased from the Military Medical Research Institute of the Logistics Department of the Guangzhou Military Region.
药品:中药组合物颗粒冲剂,华南农业大学兽医学院广东省兽药研制与安全评价重点实验室研制提供。Drugs: Traditional Chinese medicine composition granules, developed and provided by the Guangdong Provincial Key Laboratory of Veterinary Drug Development and Safety Evaluation, School of Veterinary Medicine, South China Agricultural University.
(一)小鼠LD50测定(1) Determination of mouse LD 50
小鼠60只,随机分为6组,每组10只,用灌喂法给药,给药量与浓度祥见表1,组间剂量比值为1∶0.8,剂距1∶3,一次给药后小鼠正常,连续观察7天,小鼠全部存活,无法测得LD50。60 mice were randomly divided into 6 groups, 10 in each group, administered by gavage. After taking the medicine, the mice were normal. After continuous observation for 7 days, all the mice survived, and the LD 50 could not be measured.
(二)最大耐受量试验(2) Maximum tolerance test
取小鼠30只,观察三天后进行试验,试验前一天禁食不禁水,在室温25±2℃条件下,灌喂一次,药物浓度为0.5g/ml(最大混悬浓度),给药量为1ml/20g(最大体积),一日内给药累计为25g/kg,给药后,饲养观察二周。Take 30 mice and conduct the test after three days of observation. The day before the test, they were fasted without food and water. Under the condition of room temperature 25±2°C, they were fed once with a drug concentration of 0.5g/ml (maximum suspension concentration). It is 1ml/20g (maximum volume), and the cumulative amount of administration in one day is 25g/kg. After the administration, the animals were kept and observed for two weeks.
给药后观察期间,小鼠饮食、粪便、皮毛正常,生长活动情况良好,无一动物死亡,剖检观察主要脏器未见异常。During the observation period after administration, the diet, feces, and fur of the mice were normal, and the growth and activity were in good condition. No animal died, and no abnormalities were found in the major organs of the necropsy.
表1中药组合物饮水剂LD50测定结果
讨论与小结Discussion and Summary
用药物的最大混悬浓度(0.50g/ml)灌喂给药(剂量为12.5g/kg),无法测出LD50,故测定其最大耐受量。在小鼠能够接受的最大浓度下(0.5g/ml)的最大体积(1ml)进行急性毒性测定,主要观察给药两周内的不良反应。结果小鼠在给药量为25g/kg的最大药物剂量下,观察期间未见小鼠有不良反应,尸检也未见主要脏器有异常变化,结果提示该药基本无毒性,临床使用安全。With the maximum suspension concentration of the drug (0.50g/ml) gavage administration (dose of 12.5g/kg), the LD 50 could not be measured, so the maximum tolerated dose was determined. The acute toxicity test was carried out at the maximum volume (1ml) of the maximum concentration (0.5g/ml) acceptable to mice, and the adverse reactions within two weeks of administration were mainly observed. Results Under the maximum drug dose of 25g/kg, there was no adverse reaction in the mice during the observation period, and no abnormal changes in the main organs were found in the autopsy. The results indicated that the drug was basically non-toxic and safe for clinical use.
试验二:中药组合物口服液药效学试验Experiment 2: Pharmacodynamics test of oral liquid of traditional Chinese medicine composition
1.试验材料1. Test material
1.1试验鸡:50天龄优质黄鸡。1天龄时从广东省家禽研究所粤禽公司购进,饲养至50天龄开始试验。在鸡40天龄采用红细胞凝集抑制试验(HI)测定禽流感病毒(AIV)为阴性。1.1 Test chicken: 50-day-old high-quality yellow chicken. They were purchased from Guangdong Poultry Company of Guangdong Poultry Research Institute at 1 day of age, and were bred to 50 days of age to start the experiment. Hemagglutination inhibition test (HI) was used to detect avian influenza virus (AIV) negative at the age of 40 days.
1.2饲料:从华南农业大学动物科学学院试验鸡场购进,不添加任何药物。1.2 Feed: purchased from the experimental chicken farm of the College of Animal Science, South China Agricultural University, without adding any drugs.
1.3药物:所用中药材原料均从广州市药材公司购进,华南农业大学兽医学院广东省兽药研制与安全评价重点实验室提取并配制中药组合物饮水剂(口服液)。每毫升口服液相当于1g生药。金刚烷胺购自华南农业大学华天公司,金刚乙胺购自浙江裕康制药有限公司,两种药物均经熔点测定和质谱分析与文献值一致。金刚烷胺和金刚乙胺用蒸馏水直接溶解,配成质量浓度为0.2%的药液。1.3 Drugs: All the raw materials of Chinese medicinal materials used were purchased from Guangzhou Medicinal Materials Company, extracted and prepared by the Key Laboratory of Veterinary Drug Development and Safety Evaluation of Guangdong Province, School of Veterinary Medicine, South China Agricultural University, and prepared Chinese medicinal composition drinking water (oral liquid). Each milliliter of oral liquid is equivalent to 1g of crude drug. Amantadine was purchased from Huatian Company of South China Agricultural University, and rimantadine was purchased from Zhejiang Yukang Pharmaceutical Co., Ltd. The melting point and mass spectrometry of the two drugs were consistent with the literature values. Amantadine and rimantadine are directly dissolved in distilled water to prepare a medicinal solution with a mass concentration of 0.2%.
1.4攻毒毒株:H5血清亚型禽流感病毒(半数感染浓度1.0×10-6),华南农业大学兽医学院禽病研究室保存。1.4 Challenge virus strain: H5 serotype avian influenza virus (half infection concentration 1.0×10 -6 ), preserved in the Laboratory of Poultry Disease, College of Veterinary Medicine, South China Agricultural University.
2.试验方法2. Test method
试验分组:50天龄优质黄鸡90只,雌雄各半,随机分为5组,正常对照组10只,其余各组均为20只,详细分组情况见表2。Test grouping: 90 50-day-old high-quality yellow chickens, half male and half male, were randomly divided into 5 groups, with 10 normal control groups and 20 other groups. See Table 2 for details.
攻毒:将含禽流感病毒的鸡胚尿囊液稀释为0.5×10-5浓度,每只鸡腹部肌肉注射0.2ml接种。Virus challenge: Dilute chicken embryo allantoic fluid containing avian influenza virus to a concentration of 0.5×10 -5 , and inject 0.2ml into abdominal muscle of each chicken for inoculation.
给药:试验给药各组在接种AIV当天,灌喂给药,给药各组均灌喂5ml,健康对照组和感染对照组灌喂生理盐水,每天灌喂1次,连续灌喂7天。Dosing: On the day of AIV inoculation, each group in the test administration was fed with 5ml, and the healthy control group and the infected control group were fed with normal saline, once a day, for 7 consecutive days .
药效评价标准:试验持续21天,每天观察鸡的死亡情况和临床表现,病死鸡进行尸体剖检,试验前后每只鸡进行称重。按下列标准对药效进行评价:(1)死亡:凡在试验期间,出现禽流感典型症状并死亡,尸体剖检有典型病变特征的即判定为感染死亡。(2)有效:试验结束后,所有经给药后仍存活的鸡均判定为有效,试验结束时每组存活的鸡数占试验鸡数的百分率为有效率。(3)增重:根据试验开始时和试验结束时每只鸡的体重,计算每只鸡的增重、每组试验鸡的平均体重和标准差。相对增重率是按各用药治疗组与健康对照组的平均增重之比计算,其中健康对照组设为100%。Drug efficacy evaluation criteria: the test lasted for 21 days, and the death and clinical manifestations of the chickens were observed every day. The dead chickens were autopsied, and each chicken was weighed before and after the test. Drug efficacy was evaluated according to the following criteria: (1) death: during the test period, typical symptoms of bird flu occurred and died, and those with typical pathological changes in autopsy were judged as infected and died. (2) Efficient: After the test ends, all the chickens that are still alive after administration are judged to be effective, and the percentage of the number of surviving chickens in each group to the number of test chickens at the end of the test is the effective rate. (3) Weight gain: Calculate the weight gain of each chicken, the average body weight and standard deviation of each group of test chickens according to the body weight of each chicken at the beginning of the test and the end of the test. The relative weight gain rate is calculated according to the average weight gain ratio of each medication treatment group and the healthy control group, wherein the healthy control group is set as 100%.
3.动物试验结果3. Animal test results
3.1感染对照组3.1 Infection control group
20只感染鸡中有17只在接种禽流感病毒15天内死亡,存活的3只至第21天仍健康存活。其中接种病毒后第3天死亡2只,第4天死亡3只,第4天死亡5只,第5天至第10天死亡5只,第11天至第15天死亡2只。主要症状:精神沉郁,食欲下降或废绝;羽毛松乱,眼流泪液;排水样粪便;不愿走动,严重者卧地不起,有弯颈、打转、蹦跳等神经症状。尸体剖检特征:口腔有粘液,肝、肾、胆等多个器官肿大并有出血点,出血点通常呈紫黑色。Among the 20 infected chickens, 17 died within 15 days of inoculation with the avian influenza virus, and the surviving 3 chickens were still healthy until the 21st day. Among them, 2 died on the 3rd day after inoculation, 3 died on the 4th day, 5 died on the 4th day, 5 died from the 5th to the 10th day, and 2 died from the 11th to the 15th day. Main symptoms: mental depression, loss of appetite or loss of appetite; loose feathers, tears from the eyes; drainage-like feces; reluctance to walk, severe cases lying on the ground, and neurological symptoms such as neck bending, spinning, and jumping. Autopsy features: mucus in the mouth, enlargement of liver, kidney, gallbladder and other organs with bleeding spots, usually purple-black in color.
3.2给药组3.2 Administration group
感染鸡经给药治疗后,中药组合物组只有1只死亡,成活率为95%,大部分鸡只未出现临床症状,个别鸡只出现眼流泪、羽毛松乱等轻度病症,但在试验第21天症状完全消失。金刚烷胺组鸡只死亡18只,金刚乙胺组鸡只死亡15只。具体见表2。After the infected chickens were administered and treated, only one died in the traditional Chinese medicine composition group, and the survival rate was 95%. Most of the chickens did not show clinical symptoms, and some chickens showed mild symptoms such as tearing eyes and loose feathers. Symptoms disappeared completely on the 21st day. Eighteen chickens died in the amantadine group, and 15 chickens died in the rimantadine group. See Table 2 for details.
表2三种药物对禽流感病毒感染鸡的防治效果
4.结论4 Conclusion
试验结果表明,本发明的中药组合物对人工感染禽流感病毒的鸡具有很好的保护效果,感染鸡只的存活率达95%,而传统的抗流感病毒药物“金刚烷胺”、“金刚乙胺”的有效率分别只有10%和25%,差异极显著。中药组合物组鸡只的增重与健康对照组相当,显著优于“金刚烷胺”和“金刚乙胺”组,表明中药组合物不仅对鸡禽流感具有良好的防治效果,而且对鸡的生长无不良影响。The test results show that the traditional Chinese medicine composition of the present invention has a good protective effect on chickens artificially infected with avian influenza virus, and the survival rate of infected chickens reaches 95%, while the traditional anti-influenza drugs "amantadine", "amantadine" The effective rates of "ethylamine" are only 10% and 25%, respectively, and the difference is extremely significant. The weight gain of the chickens in the Chinese medicine composition group was comparable to that of the healthy control group, which was significantly better than that of the "amantadine" and "rimantadine" groups, indicating that the Chinese medicine composition not only has a good control effect on avian influenza in chickens, but also has a good effect on chickens. No adverse effect on growth.
试验三:中药组合物饮水剂对同居感染禽流感鸡的防治效果试验Experiment 3: The control effect test of Chinese medicine composition drinking water agent on chickens infected with avian influenza in cohabitation
1.试验材料1. Test material
1.1试验鸡:50天龄优质黄鸡。1天龄时从广东省家禽研究所粤禽公司购进,饲养至50天龄开始试验。在鸡40天龄采用红细胞凝集抑制试验(HI)测定禽流感病毒(AIV)为阴性。1.1 Test chicken: 50-day-old high-quality yellow chicken. They were purchased from Guangdong Poultry Company of Guangdong Poultry Research Institute at 1 day of age, and were bred to 50 days of age to start the experiment. Hemagglutination inhibition test (HI) was used to detect avian influenza virus (AIV) negative at the age of 40 days.
1.2饲料:从华南农业大学动物科学学院试验鸡场购进,不添加任何药物。1.2 Feed: purchased from the experimental chicken farm of the College of Animal Science, South China Agricultural University, without adding any drugs.
1.3药物:所用中药材原料均从广州市药材公司购进,华南农业大学兽医学院广东省兽药研制与安全评价重点实验室提取并配制中药组合物饮水剂。每毫升饮水剂相当于1g生药。金刚乙胺购自浙江裕康制药有限公司,熔点测定和质谱分析结果与文献值一致。金刚乙胺用蒸馏水直接溶解,配成质量浓度为1%的药液。1.3 Drugs: All the raw materials of Chinese medicinal materials used were purchased from Guangzhou Medicinal Materials Company, extracted and prepared by the Key Laboratory of Veterinary Drug Development and Safety Evaluation of Guangdong Province, School of Veterinary Medicine, South China Agricultural University, and formulated drinking water doses of Chinese medicinal compositions. Each milliliter of drinking water is equivalent to 1g of crude drug. Rimantadine was purchased from Zhejiang Yukang Pharmaceutical Co., Ltd. The results of melting point determination and mass spectrometry were consistent with the literature values. Rimantadine is directly dissolved in distilled water to prepare a medicinal solution with a mass concentration of 1%.
1.4攻毒毒株:H5血清亚型禽流感病毒(半数感染浓度1.0×10-6),华南农业大学兽医学院禽病研究室保存。1.4 Challenge virus strain: H5 serotype avian influenza virus (half infection concentration 1.0×10 -6 ), preserved in the Laboratory of Poultry Disease, College of Veterinary Medicine, South China Agricultural University.
2.试验方法2. Test method
人工感染禽流感鸡只:45天龄优质黄鸡50只,雌雄各半,将含禽流感病毒的鸡胚尿囊液稀释为0.5×10-5浓度,每只鸡腹部肌肉注射0.2ml接种。接种后第3天开始发病,每日将有明显临床症状的发病鸡只做好标记,并平均分配至各试验鸡群中,直至接种后第10天。Chickens artificially infected with avian influenza: 50 45-day-old high-quality yellow chickens, half male and half female, dilute the allantoic fluid of chicken embryos containing avian influenza virus to a concentration of 0.5×10 -5 , and inject 0.2ml into the abdomen of each chicken for inoculation. On the 3rd day after inoculation, the onset of disease began, and the diseased chickens with obvious clinical symptoms were marked every day, and evenly distributed among the experimental flocks until the 10th day after inoculation.
试验分组:45天日龄优质黄鸡110只,雌雄各半,随机分为6组,正常对照组10只,其余各组均为20只,详细分组情况见表3。Test grouping: 110 45-day-old high-quality yellow chickens, half male and half male, were randomly divided into 6 groups, with 10 normal control groups and 20 other groups. See Table 3 for details.
给药:在有人工感染禽流感鸡只转入试验栏的当天开始饮水给药。饮水给药前断水3小时。中药组合物饮水剂分别按每只鸡5ml、10ml的份量,1%的金刚乙胺分别按每只鸡1ml、2ml的份量加入装有600ml自来水的饮水器中,每天1次,供鸡只自由饮水。加入药物的水饮完后,给自来水供鸡饮用。对照组供饮自来水。Dosing: On the day when chickens artificially infected with avian influenza were transferred to the test pen, water administration was started. Water was withheld for 3 hours before the administration of drinking water. The Chinese medicine composition drinking water dose is 5ml and 10ml for each chicken respectively, and 1% rimantadine is added to a drinking fountain with 600ml tap water in the amount of 1ml and 2ml for each chicken, once a day, for the chickens to freely drinking water. After drinking the water with the drug added, give tap water for the chickens to drink. The control group was given tap water.
药效评价标准:试验持续28天,每天观察鸡的死亡情况和临床表现,病死鸡进行尸体剖检,试验前后每只鸡进行称重。药效评价标准同试验二。Drug efficacy evaluation criteria: the test lasted for 28 days, and the death and clinical manifestations of the chickens were observed every day. The dead chickens were autopsied, and each chicken was weighed before and after the test. The drug efficacy evaluation standard is the same as that of Experiment 2.
人工感染的供毒源鸡只与同居试验鸡只分别记录、统计处理。The artificially infected source chickens and cohabitation test chickens were recorded and statistically processed respectively.
3.动物试验结果3. Animal test results
3.1同居感染对照组3.1 Cohabitation infection control group
20只同居感染鸡中有13只在转入人工发病禽流感鸡只后28天内死亡。其中第3天死亡1只,第4天死亡2只,第5天死亡4只,第5天至第10天死亡4只,第11天至第28天死亡2只。Thirteen of the 20 cohabiting infected chickens died within 28 days after being transferred to artificially infected chickens. One died on the 3rd day, 2 died on the 4th day, 4 died on the 5th day, 4 died from the 5th to the 10th day, and 2 died from the 11th to the 28th day.
3.2给药组3.2 Administration group
同居感染鸡经给药治疗后,中药组合物5ml剂量组全部存活,10ml剂量组有1只死亡,存活率为95%。金刚乙胺10mg和20mg剂量组鸡只分别死亡9只和11只。具体见表3。人工感染供毒源鸡只全部死亡。After cohabitation infected chickens were administered and treated, all of the 5ml dosage group of the traditional Chinese medicine composition survived, and one died in the 10ml dosage group, the survival rate was 95%. Nine and eleven chickens died in the rimantadine 10mg and 20mg dose groups, respectively. See Table 3 for details. All the source chickens artificially infected with the virus died.
表3中药组合物和金刚乙胺对同居感染禽流感鸡的防治效果
4.结论4 Conclusion
同居感染的药物防治试验结果表明,本发明的中药组合物对同居感染禽流感鸡只具有良好的保护效果,每只每天供5ml和10ml饮水剂的存活率分别达100%和95%,显著优于金刚乙胺的保护效果。此外,同居感染对照组的鸡只并未全部发病,存活率为35%。The results of the drug prevention and control test of cohabitation infection show that the Chinese medicine composition of the present invention has a good protective effect on cohabitation infected chickens, and the survival rate of each chicken with 5ml and 10ml drinking water per day reaches 100% and 95% respectively, which is significantly better than that of cohabitation chickens. on the protective effect of rimantadine. In addition, not all chickens in the cohabitation-infected control group became ill, and the survival rate was 35%.
中药组合物组鸡只的增重比健康对照组稍差,但差异不显著,相对健康组分别为94.32%和94.07%。金刚乙胺对鸡的生长有明显影响,10mg和20mg剂量组增重比健康对照组分别下降12%和24%。同居感染试验表明本发明的中药组合物对自然感染禽流感鸡具有良好的防治效果。The weight gain of the chickens in the traditional Chinese medicine composition group was slightly lower than that of the healthy control group, but the difference was not significant, and the relative health group was 94.32% and 94.07% respectively. Riantadine has a significant effect on the growth of chickens, and the weight gain of the 10mg and 20mg dose groups is 12% and 24% lower than that of the healthy control group, respectively. The cohabitation infection test shows that the traditional Chinese medicine composition of the present invention has a good control effect on chickens naturally infected with avian influenza.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100114323A CN100337651C (en) | 2005-03-15 | 2005-03-15 | Chinese medicine composition for preventing bird flu |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100114323A CN100337651C (en) | 2005-03-15 | 2005-03-15 | Chinese medicine composition for preventing bird flu |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1682843A CN1682843A (en) | 2005-10-19 |
CN100337651C true CN100337651C (en) | 2007-09-19 |
Family
ID=35262462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100114323A Expired - Fee Related CN100337651C (en) | 2005-03-15 | 2005-03-15 | Chinese medicine composition for preventing bird flu |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100337651C (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100431581C (en) | 2006-01-20 | 2008-11-12 | 丽珠医药集团股份有限公司 | Traditional Chinese medicine composition for treating fowl influenza, its preparation method and uses |
CN100364414C (en) * | 2006-02-06 | 2008-01-30 | 扬中牧乐药业有限公司 | Compound plant extract for preventing avian influenza and preparation thereof |
CN101283688B (en) * | 2007-04-12 | 2011-10-26 | 上海利康消毒高科技有限公司 | Pure Chinese medicine anti-avian influenza air disinfectant and its preparation method |
CN101244146B (en) * | 2008-02-22 | 2010-11-10 | 辽宁职业学院 | Method for preparing Chinese medicine injection for treating high-pathogenicity blue-ear disease of pig |
CN101574407B (en) * | 2009-06-24 | 2011-04-13 | 贾高增 | Drug for preventing cold and preparation method thereof |
CN101966285B (en) * | 2010-10-13 | 2012-05-23 | 郑州后羿制药有限公司 | Traditional Chinese medicine and traditional Chinese medicine aerosol for preventing and curing chicken respiratory diseases and preparation method thereof |
CN102920890B (en) * | 2011-08-12 | 2014-06-04 | 范晓飞 | Traditional Chinese medicinal composition for treating fever diseases of poultries |
CN103859168B (en) * | 2014-04-03 | 2015-08-05 | 常熟理工学院 | The anti-avian influenza feed addictive of a kind of large-scale ecological poultry and preparation thereof, using method |
CN104383056B (en) * | 2014-11-26 | 2017-11-21 | 河南后羿实业集团有限公司 | A kind of Chinese medicine composition for preventing and treating avian influenza |
CN105053635A (en) * | 2015-08-04 | 2015-11-18 | 贵州柳江畜禽有限公司 | Layering hen breeding method for controlling drug residues in eggs |
CN105055507A (en) * | 2015-09-24 | 2015-11-18 | 江苏农牧科技职业学院 | Traditional Chinese medicine composition for preventing and treating Newcastle disease, as well as preparation method and application thereof |
CN106963905A (en) * | 2017-03-30 | 2017-07-21 | 蒋世芬 | A kind of medicine of avian typhoid |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1557369A (en) * | 2004-01-14 | 2004-12-29 | 河北农业大学 | A kind of medicine for preventing and treating chicken influenza |
-
2005
- 2005-03-15 CN CNB2005100114323A patent/CN100337651C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1557369A (en) * | 2004-01-14 | 2004-12-29 | 河北农业大学 | A kind of medicine for preventing and treating chicken influenza |
Also Published As
Publication number | Publication date |
---|---|
CN1682843A (en) | 2005-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5620985B2 (en) | Traditional Chinese medicine composition for swine flu treatment, its preparation method and use | |
CN1839988A (en) | Traditional Chinese medicine composition for treating fowl influenza, its preparation method and uses | |
CN100337651C (en) | Chinese medicine composition for preventing bird flu | |
CN1840064A (en) | Medicine composition for treating bird flu, its preparation method and use | |
CN101332255A (en) | Traditional Chinese medicine extract for preventing avian influenza and preparation method | |
CN102091151B (en) | Traditional medicinal composition with wind-dispelling and dampness-removing function and preparation method thereof | |
CN1221277C (en) | Prophylaxis medication for treating pneumonia, bronchitis, pharyngitis and upper respiratory tract infection as well as its preparing method | |
CN110151820A (en) | Screening and preparation method of Mongolian medicinal formula for preventing and treating lamb's diarrhea | |
CN105982995A (en) | Specific traditional Chinese veterinary oral medicine for treating chronic hog cholera | |
CN103636968A (en) | Anti-avian influenza feed additive | |
CN100337645C (en) | Medicine composition for treating acute pharyngitis and its prepn | |
CN102813713B (en) | Rhizoma dryopteris crassirhizomae and fructus crataegi composition, preparation method and application of composition | |
CN101804112B (en) | Preparation method and application of Cyrtomium fortunei and ebony traditional Chinese medicine composite | |
CN1680355A (en) | Preparation of suaveolic flavone for treating chronic pharyngitis and chronic tonsilltiis | |
CN1220495C (en) | Traditional Chinese medicine for treating upper respiratory tract infection and its preparation method | |
CN1679864A (en) | Chinese medicine preparation for treating bronchitis | |
CN103356717B (en) | Rhizoma Dryopteris Crassirhizomatis extract and its use in preparation of viral disease controlling medicines | |
CN1742775A (en) | Medicine composition for preventing and treating orthopedic diseases | |
CN115671192B (en) | Traditional Chinese medicine composition for preventing and treating taeniasis of ducks | |
CN103005153B (en) | A health product for improving animal immunity and its preparation method and application | |
CN1593564A (en) | Medicine for treating cold and its preparing process | |
CN107019743A (en) | A kind of Chinese herbal feed additive for preventing and treating animal viral disease and preparation method thereof | |
CN108096435A (en) | A kind of traditional Chinese powder medicine for being used to prevent swine flu | |
CN1500505A (en) | Medication composition for children 's virus pneumonia and its preparation method | |
CN1943624A (en) | Medicinal composition for treating common cold and its preparing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070919 Termination date: 20170315 |